Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.
<h4>Background</h4>Non-AIDS conditions such as cardiovascular disease and non-AIDS defining cancers dominate causes of morbidity and mortality among persons with HIV on suppressive combination antiretroviral therapy. Accurate estimates of disease incidence and of risk factors for these c...
Saved in:
| Main Authors: | Christopher J Miller, Jason V Baker, Alison M Bormann, Kristine M Erlandson, Katherine Huppler Hullsiek, Amy C Justice, Jacqueline Neuhaus, Roger Paredes, Kathy Petoumenos, Deborah Wentworth, Alan Winston, Julian Wolfson, James D Neaton, INSIGHT SMART Study Group, ESPRIT Study Group |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0095061 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
by: Birgit Grund, et al.
Published: (2016-01-01) -
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
by: Amanda Mocroft, et al.
Published: (2012-01-01) -
Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.
by: Jorge A Tavel, et al.
Published: (2010-02-01) -
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
by: Lewis H Kuller, et al.
Published: (2008-10-01) -
Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
by: Anna Maria Geretti, et al.
Published: (2013-01-01)